Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ASC-69 (Synonyms: ASC69, APY-69, APY69)

Catalog No. T82960 Copy Product Info
🥰Excellent
ASC-69 (APY69) is a potent small-molecule PD-1/PD-L1 signaling pathway inhibitor that restores T-cell immune function by blocking the interaction between PD-1 and PD-L1. ASC-69 is widely used in both in vitro and in vivo experimental models related to tumor immunology, immune checkpoint regulatory mechanism research, and anti-tumor drug development to evaluate its immune-enhancing and anti-cancer potential.

ASC-69

Copy Product Info
🥰Excellent
Catalog No. T82960
Synonyms ASC69, APY-69, APY69

ASC-69 (APY69) is a potent small-molecule PD-1/PD-L1 signaling pathway inhibitor that restores T-cell immune function by blocking the interaction between PD-1 and PD-L1. ASC-69 is widely used in both in vitro and in vivo experimental models related to tumor immunology, immune checkpoint regulatory mechanism research, and anti-tumor drug development to evaluate its immune-enhancing and anti-cancer potential.

ASC-69
Cas No. 1216665-50-7
Pack SizePriceUSA StockGlobal StockQuantity
5 mgInquiry-In Stock
50 mgInquiry-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
ASC-69 (APY69) is a potent small-molecule PD-1/PD-L1 signaling pathway inhibitor that restores T-cell immune function by blocking the interaction between PD-1 and PD-L1. ASC-69 is widely used in both in vitro and in vivo experimental models related to tumor immunology, immune checkpoint regulatory mechanism research, and anti-tumor drug development to evaluate its immune-enhancing and anti-cancer potential.
Targets&IC50
PD-L1:1.86 nM
In vitro
In HTRF assays, ASC-69 inhibited the PD-1/PD-L1 interaction with an IC50 of 1.86 nM by inducing PD-L1 dimerization [1].
In vivo
In syngeneic mouse models, including CT26 and MC38, oral or intraperitoneal (i.p.) administration of ASC-69 results in dose-dependent tumor growth inhibition. The antitumor efficacy observed is comparable to that of anti-PD-L1 monoclonal antibodies. The presence of the difluoromethyleneoxy linker contributes to the compound's metabolic stability and oral bioavailability in rodent models
SynonymsASC69, APY-69, APY69
Chemical Properties
Molecular Weight345.4
FormulaC19H19N7
Cas No.1216665-50-7
SmilesN#CCC1=CC=C(C=C1)NC=2N=C(C=C(N2)C)NC3=NNC(=C3)C4CC4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (231.62 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8952 mL14.4760 mL28.9519 mL144.7597 mL
5 mM0.5790 mL2.8952 mL5.7904 mL28.9519 mL
10 mM0.2895 mL1.4476 mL2.8952 mL14.4760 mL
20 mM0.1448 mL0.7238 mL1.4476 mL7.2380 mL
50 mM0.0579 mL0.2895 mL0.5790 mL2.8952 mL
100 mM0.0290 mL0.1448 mL0.2895 mL1.4476 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ASC-69 | purchase ASC-69 | ASC-69 cost | order ASC-69 | ASC-69 chemical structure | ASC-69 in vivo | ASC-69 in vitro | ASC-69 formula | ASC-69 molecular weight